Printer Friendly
Dictionary, Encyclopedia and Thesaurus - The Free Dictionary
1,762,216,372 visitors served.
forum mailing list For webmasters
?
New: Language forums
Dictionary/
thesaurus
Medical
dictionary
Legal
dictionary
Financial
dictionary
Acronyms
 
Idioms
Encyclopedia
Wikipedia
encyclopedia
?

allograft
(redirected from allograft rejection)

   Also found in: Dictionary/thesaurus, Encyclopedia, Wikipedia 0.01 sec.
allograft /al·lo·graft/ (al´o-graft) a graft between individuals of the same species, but of different genotypes. Called also homograft.
al·lo·graft (l-grft)
n.
A graft of tissue obtained from a donor genetically different from, though of the same species as the recipient. Also called allogeneic graft, allogeneic homograft, homograft, homologous graft, homoplastic graft.

Allograft
Tissue that is taken from one person's body and grafted to another person.

allograft
[al′əgraft]
Etymology: Gk, allos, other + graphion, stylus
surgical transplantation of tissue between two genetically dissimilar individuals of the same species, such as between two humans who are not monozygotic twins. Tissues commonly used for allografts include cornea, cartilage, bone, artery, and cadaver skin stored in a skin-tissue bank. Also called allogenic graft, homogenous graft, homograft, homologous graft. Compare autograft, isograft, xenograft. See also graft.

allograft
a graft between individuals of the same species, but of a different genotype. Formerly called homograft.

allograft rejection

allograft
Allogeneic graft Immunology A graft–organ, tissues, or cells donated from a genetically distinct–in humans, allogeneic at one or more MHC loci—individual of the same species. See Renal transplantation. Cf Autograft, Xenograft.


How to thank TFD for its existence? Tell a friend about us, add a link to this page, add the site to iGoogle, or visit webmaster's page for free fun content.
?Page tools
Printer friendly
Cite / link
Email
Feedback
Add definition
? Mentioned in ? References in periodicals archive
 
Although allograft rejection is only the second leading cause of mortality for cardiac transplant recipients, immunosuppression is the primary source of morbidity.
In 2004, XDx completed the validation phase of the CARGO (Cardiac Allograft Rejection and Gene Expression Observational) study in anticipation of a December 2004 launch of AlloMap molecular expression testing, the company's molecular expression test targeting the post-cardiac transplantation patient management market.
of the US Food and Drug Administration (FDA) has granted the Company "Orphan Drug Designation" for its investigational antibodies to interferon-gamma to treat Immunologic Corneal Allograft Rejection.
 
Medical browser? ? Full browser
 
 
Medical Dictionary
?

Disclaimer | Privacy policy | Feedback | Copyright © 2009 Farlex, Inc.
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a Terms of Use.